OFM
TBIO

Omega Fund Management’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Omega Fund Management’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,437,603
Closed -$24.3M – 16
2020
Q1 		$24.3M Hold
2,437,603
– – 10.06% 5
2019
Q4 		$19.8M Hold
2,437,603
– – 6.32% 4
2019
Q3 		$24.2M Hold
2,437,603
– – 7.46% 4
2019
Q2 		$30.8M Hold
2,437,603
– – 7.85% 4
2019
Q1 		$24.8M Hold
2,437,603
– – 7.96% 3
2018
Q4 		$18.3M Buy
2,437,603
+2
+0% +$15 13.55% 2
2018
Q3 		$24.4M Hold
2,437,601
– – 11.53% 3
2018
Q2 		$30.8M Buy
+2,437,601
New +$29.5M 22.75% 1

Other funds holding TBIO

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $122M AUM 26.28% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Omega Fund Management's TBIO Position: Q2 2020 in Review

Omega Fund Management sold out of Translate Bio, Inc. Common Stock (TBIO) in Q2 2020, closing a stake of 2,437,603 shares — an estimated $24.3M sold.

Omega Fund Management first reported a position in TBIO in Q2 2018 and held it in 8 quarters. The position peaked at $30.8M in Q2 2018. 133 funds tracked by Wall St. Rank hold TBIO as of Q2 2020.

  • Omega Fund Management reported no remaining Translate Bio, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Omega Fund Management sold 2,437,603 Translate Bio, Inc. Common Stock shares in Q2 2020, an estimated $24.3M.
  • Omega Fund Management first reported a position in Translate Bio, Inc. Common Stock in Q2 2018 and held it in 8 quarters.
  • Omega Fund Management's Translate Bio, Inc. Common Stock position peaked at $30.8M in Q2 2018.
  • 133 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q2 2020.

Based on Omega Fund Management's 13F filing for Q2 2020, filed 17 Aug 2020.